Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis
Multiple Sclerosis

About this trial
This is an interventional treatment trial for Multiple Sclerosis focused on measuring Multiple Sclerosis, cognitive rehabilitation, REHACOP
Eligibility Criteria
Inclusion Criteria:
i) age 20-60 years
ii) either male or female
iii) patients with relapsing-remitting, secondary progressive or primary progressive MS
Exclusion criteria:
i) presence of dementia
ii) have suffered an exacerbation during the previous month to the cognitive assessment
iii) being treated with corticosteroids
iv) presence of other neurological disorder
v) history of stroke or traumatic brain injury resulting in more than 30 minutes loss of consciousness
vi) presence of psychiatric disorders
Sites / Locations
- University of Deusto
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Cognitive remediation program: REHACOP
Control group
Cognitive rehabilitation program (REHACOP) including intervention in: attention, memory, processing speed, language, executive functioning and social cognition during 3 months, 3 times per week
No intervention was administered.